beyond trial update: luspatercept in non-transfusion-dependent β-thalassemia
Published 1 year ago • 689 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
8:38
treating transfusion dependent and independent beta-thalassemia, and believe/beyond trial updates
-
1:26
durable symptom improvement in ntd thalassemia treated with luspatercept in the beyond trial
-
3:01
long-term results of believe: luspatercept in adults with transfusion-dependent beta-thalassemia
-
1:34
follow-up from the commands trial beyond the primary endpoint: luspatercept versus esa-based therapy
-
2:35
long-term results of the believe study: luspatercept in patients with beta-thalassemia
-
7:08
believe: β-thalassemia treatment with luspatercept reduces transfusion burden
-
2:28
results of the believe study: luspatercept for the treatment of beta-thalassemia
-
1:39
luspatercept in patients with hbe/β‑thalassemia: a subgroup analysis from the believe study
-
8:21
thalassemia major home treatment | thalassemia major
-
13:52
living without thalassaemia | the experience of simona and giuseppe with gene therapy
-
21:34
beta-thalassemia trait vs iron deficiency anemia || back to basics || dr. shonali chandra
-
5:33
luspatercept reduces transfusion burden in β-thalassemia
-
11:42
thalassemia highlights at ash 2023: novel therapies, trial updates & the value of precision medicine
-
1:46
how would the approval of luspatercept benefit the treatment landscape in myelofibrosis
-
5:49
beti-cel gene therapy for transfusion-dependent β-thalassemia: 7-year follow up data
-
1:40
long-term follow-up of luspatercept: response duration and progression to aml
-
0:42
upcoming trial updates in all
-
4:21
evaluating luspatercept in combination with esas for the treatment of anemia in lr-mds
-
5:48
thalassemia: alpha & beta-thalassemias, genetics, pathophysiology, diagnosis & treatment, animation
-
1:10
current and emerging therapeutic strategies in beta-thalassemia
-
1:49:21
luspatercept therapy in thalassemia: an update
-
9:28
new double targeting approach for beta-thalassemia